182 related articles for article (PubMed ID: 25190727)
21. Human papillomavirus screening in north Indian women.
Pandey S; Mishra M; Chandrawati
Asian Pac J Cancer Prev; 2012; 13(6):2643-6. PubMed ID: 22938435
[TBL] [Abstract][Full Text] [Related]
22. Urine miRNA signature as a potential non-invasive diagnostic and prognostic biomarker in cervical cancer.
Aftab M; Poojary SS; Seshan V; Kumar S; Agarwal P; Tandon S; Zutshi V; Das BC
Sci Rep; 2021 May; 11(1):10323. PubMed ID: 33990639
[TBL] [Abstract][Full Text] [Related]
23. T Cell Receptor Repertoires Acquired
Christley S; Ostmeyer J; Quirk L; Zhang W; Sirak B; Giuliano AR; Zhang S; Monson N; Tiro J; Lucas E; Cowell LG
Front Immunol; 2021; 12():624230. PubMed ID: 33868241
[TBL] [Abstract][Full Text] [Related]
24. Molecular basis for advances in cervical screening.
Doorbar J; Cubie H
Mol Diagn; 2005; 9(3):129-42. PubMed ID: 16271014
[TBL] [Abstract][Full Text] [Related]
25. Human Papillomavirus in the region of La Ribera-Valencia: Present and future.
Burgos-Teruel A; Bernet L; Gil-Tomás JJ; Jover-García J; López A; Osca A
Rev Esp Quimioter; 2020 Apr; 33(2):103-109. PubMed ID: 32080997
[TBL] [Abstract][Full Text] [Related]
26. Cervical human papillomavirus testing to triage borderline abnormal pap tests in HIV-coinfected women.
DʼSouza G; Burk RD; Palefsky JM; Massad LS; Strickler HD;
AIDS; 2014 Jul; 28(11):1696-8. PubMed ID: 25232904
[No Abstract] [Full Text] [Related]
27. Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis.
Pathak N; Dodds J; Zamora J; Khan K
BMJ; 2014 Sep; 349():g5264. PubMed ID: 25232064
[TBL] [Abstract][Full Text] [Related]
28. Invasive Cervical Cancer After a Positive Pap Test Result and Negative Human Papillomavirus Test Result.
Locke A; Shah NR; Fetterman B; Poitras N; Wi S; Castle PE; Wentzensen N; Kinney W; Clarke MA; Lorey T
Obstet Gynecol; 2021 Oct; 138(4):580-581. PubMed ID: 34623071
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic Test Accuracy of First-Void Urine Human Papillomaviruses for Presence Cervical HPV in Women: Systematic Review and Meta-Analysis.
Bober P; Firment P; Sabo J
Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948919
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer.
Liu SS; Chan KKL; Chu DKH; Wei TN; Lau LSK; Ngu SF; Chu MMY; Tse KY; Ip PPC; Ng EKO; Cheung ANY; Ngan HYS
Mol Oncol; 2018 Dec; 12(12):2009-2022. PubMed ID: 30221475
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic Value of Vaginal Microecology, Serum miR-18a, and PD-L1 for Identifying HPV-Positive Cervical Cancer.
Zhang Y; Qiu S; Guo Y; Zhang J; Wu X; Hong G
Technol Cancer Res Treat; 2021; 20():1533033821995281. PubMed ID: 33632085
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of high-risk human papillomavirus among women in two English-speaking Caribbean countries.
Andall-Brereton G; Brown E; Slater S; Holder Y; Luciani S; Lewis M; Irons B
Rev Panam Salud Publica; 2017 Jun; 41():e41. PubMed ID: 28614466
[TBL] [Abstract][Full Text] [Related]
33. Clinical Value of Serum miR-106a in the Diagnosis and Prognosis of Human Papillomavirus-Positive Cervical Cancer.
Rao X; Jiang J; Wang Y; Ma X; Liu S
Intervirology; 2023; 66(1):54-62. PubMed ID: 36646059
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts.
Sahasrabuddhe VV; Luhn P; Wentzensen N
Future Microbiol; 2011 Sep; 6(9):1083-98. PubMed ID: 21958146
[TBL] [Abstract][Full Text] [Related]
35. MOLECULAR MARKERS FOR THE DIAGNOSIS OF HIGH-RISK HUMAN PAPILLOMAVIRUS INFECTION AND TRIAGE OF HUMAN PAPILLOMAVIRUS-POSITIVE WOMEN.
Torres-Poveda K; Piña-Sánchez P; Vallejo-Ruiz V; Lizano M; Cruz-Valdez A; Juárez-Sánchez P; Garza-Salazar J; Manzo-Merino J
Rev Invest Clin; 2020; 72(4):198-212. PubMed ID: 33064696
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus infection and anxiety: analyses in women with low-grade cervical cytological abnormalities unaware of their infection status.
Johnson CY; Sharp L; Cotton SC; Harris CA; Gray NM; Little J;
PLoS One; 2011; 6(6):e21046. PubMed ID: 21698168
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA Levels in Cervical Cancer Samples and Relationship with Lesion Grade and HPV Infection.
Hoelzle CR; Arnoult S; Borém CRM; Ottone M; de Magalhães KCSF; da Silva IL; Simões RT
Microrna; 2021; 10(2):139-145. PubMed ID: 34086555
[TBL] [Abstract][Full Text] [Related]
38. Serum miRNA Combined With Transvaginal Color Doppler Ultrasound Diagnosis Clinical Research on Cervical Cancer.
Wang Y; Yang J; Wang Y
J Ultrasound Med; 2024 Apr; 43(4):791-798. PubMed ID: 38269478
[TBL] [Abstract][Full Text] [Related]
39. ["I felt myself getting sick:" women's perceptions and understandings of a positive human papillomavirus test in Jujuy, Argentina].
Szwarc L; Sánchez Antelo V; Paolino M; Arrossi S
Salud Colect; 2021 Aug; 17():e3572. PubMed ID: 34752024
[TBL] [Abstract][Full Text] [Related]
40. A Comparative Study for Selectivity of Micronuclei in Cervical Exfoliated Cells on Chronic Boron Effects.
Yıldırım H; Göker A; Demirci H; Güvenal T; Korkmaz M
J Cytol; 2019; 36(2):75-78. PubMed ID: 30992640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
